Dr. Robert E. Beasley, MD

Dr. Beasley practices at Miami Beach Surgery Center, LLC in Miami Beach, Florida.

Dr. Beasley's NPI, 1740289016, was assigned on July 19, 2005. Dr. Beasley graduated from Wake Forest School of Medicine in 1983. Dr. Beasley holds Florida license ME48730.

Dr. Beasley's primary practice is Miami Beach Surgery Center, LLC, at 400 W 41st St, Miami Beach, FL 33140 in Miami-Dade County. The practice phone is (305) 405-6910.

Dr. Beasley's primary practice is Miami Beach Surgery Center, LLC in Miami Beach, Florida. The medical group on file is Palm Vascular Centers. Dmand AI also links Dr. Beasley to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Beasley practices, 2 sites in all. Vendor and product names are available with a free account.

Vascular and interventional radiology is Dr. Beasley's primary specialty in the NPI Registry, under taxonomy code 2085R0204X. Dr. Beasley is board certified in interventional radiology and diagnostic radiology by the American Board of Radiology. Dmand AI has Dr. Beasley's licenses on file in 2 states: Florida and North Carolina.

CMS data shows 1,346 Medicare services from Dr. Beasley across 19 procedure codes in 2024, for 155 Medicare patients. Medicare paid $603,901 for them. Every service was in an office.

CMS counts 155 Medicare patients who saw Dr. Beasley in 2024. The largest group is 75 to 84, with 72 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 33% are also on Medicaid. Their average risk score is 2.16, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Beasley's median patient age at 72, with 54% women.

In 2024, Dr. Beasley wrote 188 Medicare Part D claims for 84 patients. 84% of them were for generic drugs. CMS names the drug for 151 of them, across 3 drugs with 11 or more claims each, at $15,161 in total drug cost. In 2023, CMS named 101 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Beasley for performance year 2024, reported as part of a group. Dr. Beasley accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 60 procedures of leg revascularization (restoring blood flow) by Dr. Beasley, more than 96% of the clinicians it reports for that procedure.

Dmand AI links 26 papers to Dr. Beasley, published from 2013 to 2025. 2019 was the busiest year, with 4. The most frequent topics are Limb Salvage, Peripheral Arterial Disease and Femoral Artery. Dr. Beasley has published most often in J Endovasc Ther. Dr. Beasley's most frequent co-authors are George L. Adams, MD, Suman Annambhotla, MD and Matthew C. Bunte, MD.

Dmand AI links Dr. Beasley to 14 clinical trials. 6 are still active or recruiting. Conditions studied include Peripheral Arterial Disease, Peripheral Vascular Diseases and Chronic Limb-Threatening Ischemia. C. R. Bard sponsors the most, 4. Open Payments lists research payments to Dr. Beasley that name 4 trials.

CMS Open Payments shows 1,283 general payments to Dr. Beasley from 64 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 42% of the total. C. R. Bard, Inc. & Subsidiaries paid the most, $199,020. It also lists 14 research payments totaling $112,769 from 2016 to 2021, naming 4 clinical trials.

Dr. Beasley graduated from Wake Forest School of Medicine in 1983.

Dr. Beasley is in network with 13 carriers, including United Healthcare, Cigna and Elevance. HMO plans come from the most carriers, 9. Check the plan with the practice before a visit.